Grade: C — Some Red Flags, Investigate
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Fiscal year ended August 28, 2025) + Yahoo Finance
Auditor: PricewaterhouseCoopers LLP — Clean opinion (1 critical audit matter: CHIPS Act funding agreements)
One-line verdict: Micron's C grade reflects the extreme cyclicality of the memory semiconductor business, not accounting manipulation. Revenue surged 49% to $37.4B as the AI-driven demand cycle propelled DRAM and NAND pricing recovery, but FCF fell below 50% of net income for two years running — the single fail flag — because Micron is spending $15.9B annually on fabs to meet HBM and AI chip demand. The M-Score of -2.73 is clean. Gross margin swung +17.4pp in one year (22.4% to 39.8%), triggering a watch flag, but this is the nature of memory cycles, not financial engineering. Investors should focus on whether the massive CapEx bet pays off.
| Metric | Result |
|---|---|
| Red Flags | **1** (FCF < 50% of NI for 2 years) |
| Watch Items | **2** (gross margin swing, cash vs debt) |
| Checks Completed | **18/18** |
| Beneish M-Score | **-2.73** (clean) |
| Auditor | PricewaterhouseCoopers LLP — Unqualified opinion |
The Memory Cycle Turns
Micron Technology is the world's fourth-largest semiconductor company by revenue and the only U.S.-based manufacturer of DRAM and NAND memory. The company operates fabrication facilities in Taiwan, Singapore, Japan, the United States, Malaysia, China, and India.
Note: Micron's fiscal year ends in late August. FY2025 ended August 28, 2025.
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|---|
| Revenue | $30.8B | $15.5B | $25.1B | $37.4B | +49% |
| Net Income | $8.7B | ($5.8B) | $0.8B | $8.5B | Recovery |
| Gross Margin | 45.2% | -9.1% | 22.4% | 39.8% | +17.4pp |
| Net Margin | 28.2% | -37.5% | 3.1% | 22.8% | Recovery |
| ROE | 17.4% | -13.2% | 1.7% | 15.8% | Recovery |
From the 10-K: "Revenue for 2025 increased 49% as compared to 2024 primarily due to increases in sales of both DRAM and NAND products." Revenue increased further "on higher bit shipments due to demand growth."
The revenue trajectory tells the story of a violent memory cycle: $30.8B (FY2022 peak) to $15.5B (FY2023 trough, -50%) back to $37.4B (FY2025, +141% from trough). This cyclicality is the defining characteristic of Micron's business model and creates unique challenges for earnings quality analysis.
Income Statement Detail (from 10-K)
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $37,378M | $25,111M | $15,540M |
| Cost of goods sold | $22,505M | $19,498M | $16,956M |
| Gross margin | $14,873M | $5,613M | ($1,416M) |
| R&D | $3,798M | $3,430M | $3,114M |
| SG&A | $1,205M | $1,129M | $920M |
| Restructure & impairments | $39M | $1M | $171M |
| Operating income (loss) | $9,770M | $1,304M | ($5,745M) |
| Interest income | $496M | $529M | $468M |
| Interest expense | ($477M) | ($562M) | ($388M) |
| Net income (loss) | $8,539M | $778M | ($5,833M) |
The $15.9 Billion CapEx Bet
Micron's most significant financial decision is the massive capital expenditure program. Per the 10-K cash flow statement: "$15.86 billion of expenditures for property, plant, and equipment" in FY2025, nearly double the $8.39B spent in FY2024.
This spending is driven by the AI boom — specifically High Bandwidth Memory (HBM) demand from data center customers building out GPU clusters. The 10-K notes the company has entered into "direct funding agreements with the U.S. Department of Commerce for up to $6.4 billion in direct funding pursuant to the U.S. CHIPS Act for the Company's U.S. manufacturing expansion and modernization projects in Idaho, New York, and Virginia."
The cash flow impact: "For 2025, net cash used for investing activities consisted primarily of $15.86 billion of expenditures for property, plant, and equipment and $192 million of net outflows from purchases, maturities, and sales of available-for-sale securities, partially offset by $2.01 billion of proceeds from government incentives to offset capital expenditures."
This is why FCF fails our screen — $17.5B in CFFO minus $15.9B in CapEx leaves only $1.7B in FCF against $8.5B net income (FCF/NI = 0.20). The business is cash-flow positive, but it is reinvesting nearly all cash back into future capacity.
Cash Flow: Strong Operations, Heavy Investment
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating Cash Flow | $1.6B | $8.5B | $17.5B |
| CapEx | ($7.7B) | ($8.4B) | ($15.9B) |
| Free Cash Flow | ($6.1B) | $0.1B | $1.7B |
| CFFO / Net Income | -0.27 | 10.93 | 2.05 |
CFFO/NI of 2.05 is excellent — each dollar of profit generated $2.05 in operating cash. The negative accruals ratio (-10.9%) is outstanding and means cash earnings far exceed accrual earnings. The issue is not earnings quality — it is capital allocation. Micron is plowing cash into fabs at a rate that leaves minimal free cash flow.
Per the filing, the increase in operating cash flow "was primarily due to higher net income in 2025 adjusted for non-cash items, the effect of changes in receivables and accounts payable and accrued expenses, and a decrease in inventory."
The 18-Point Screening
Revenue Quality
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO | Pass | DSO 70 days, -9 days YoY. Improving |
| A2 | AR vs Revenue | Pass | AR growth 32.2% vs revenue growth 48.9% |
| A3 | Revenue vs CFFO | Pass | Revenue +48.9%, CFFO +106.0%. Cash outpaces revenue |
All three revenue quality checks pass. DSO actually improved (70 days vs. 79 days prior year), AR grew slower than revenue (32% vs. 49%), and CFFO grew more than double revenue growth. This is the profile of a company with accelerating genuine demand, not one pulling revenue forward.
Expense Quality
| # | Check | Result | Detail |
|---|---|---|---|
| B1 | Inventory | Pass | Inventory declined 5.9% vs COGS +15.4% |
| B2 | CapEx | Pass | CapEx growth 89.1% vs revenue 48.9%. Normal |
| B3 | SG&A Ratio | Pass | SG&A/Gross Profit = 8.1%, excellent |
| B4 | Gross Margin | Watch | Gross margin swung +17.4pp (22.4% to 39.8%) |
B4: The 17.4pp gross margin swing is flagged because extreme margin changes can indicate earnings manipulation (channel stuffing, warranty reserve releases, etc.). In Micron's case, this is the well-understood memory cycle dynamic: when demand surges and pricing improves, fixed manufacturing costs are spread over more units at higher ASPs. The 10-K confirms this is demand-driven: "Revenue for 2025 increased 49% as compared to 2024 primarily due to increases in sales of both DRAM and NAND products." Inventory declining 5.9% while revenue surged 49% confirms the margin improvement is real (selling from existing stock at higher prices).
Note that the FY2022 gross margin was 45.2%, so the current 39.8% has not yet returned to prior peak levels — suggesting the cycle still has room to run.
Cash Flow Quality
| # | Check | Result | Detail |
|---|---|---|---|
| C1 | CFFO vs NI | Pass | Ratio 2.05. Excellent cash conversion |
| C2 | FCF | Fail | FCF < 50% of NI for 2 years |
| C3 | Accruals | Pass | -10.9% accruals ratio. Excellent |
| C4 | Cash vs Debt | Watch | Cash $10.3B covers 67% of debt $15.3B |
C2: This is the sole fail. FCF/NI was 0.20 in FY2025 and 0.16 in FY2024 — both below our 0.50 threshold for two consecutive years. But this is a CapEx story, not an earnings quality story. Operating cash flow of $17.5B against net income of $8.5B (2.05x) shows the business generates abundant cash. The issue is that $15.9B goes right back into fab construction. With CHIPS Act funding offsetting $2.0B of that CapEx, the net investment is still massive.
C4: Cash of $10.3B covers 67% of total debt of $15.3B. Debt/EBITDA is only 0.8x and interest coverage is 20.6x ($9.8B operating income vs. $477M interest expense). The balance sheet is healthy.
Balance Sheet
| # | Check | Result | Detail |
|---|---|---|---|
| D1 | Goodwill + Intangibles | Pass | $1.6B = 3% of equity. Negligible |
| D2 | Leverage | Pass | Debt/EBITDA 0.8x. Healthy |
| D3 | Soft Asset Growth | Pass | Other assets 83.3% vs revenue 48.9%. Normal |
| D4 | Impairment | Pass | Write-offs normal |
The balance sheet is clean. Goodwill of $1.15B includes a $101M impairment charge recognized in FY2023 for the former Storage Business Unit reporting unit. Per the filing: "As a result of reorganizing our segments in the fourth quarter of 2025, we performed a quantitative goodwill impairment assessment for each of our reporting units immediately before and after our business unit reorganization. We concluded based on both our pre- and post-reorganization impairment tests that goodwill was not impaired."
M&A Risk
| # | Check | Result | Detail |
|---|---|---|---|
| E1 | Post-Acquisition FCF | Pass | FCF after acquisitions positive |
| E2 | Goodwill Surge | Pass | Intangibles grew only 2% YoY |
Beneish M-Score
| # | Check | Result | Detail |
|---|---|---|---|
| F1 | M-Score | Pass | -2.73 (< -2.22). Unlikely manipulator |
The M-Score is clean at -2.73. Interestingly, the SGI (Sales Growth Index) is elevated at 1.489 — reflecting the 49% revenue surge — but this is offset by benign values in GMI (0.562, reflecting improving margins from a low base) and SGAI (0.717, reflecting operating leverage). The TATA (Total Accruals to Total Assets) of -0.1085 is strongly negative, confirming cash-based earnings.
Critical Audit Matter: CHIPS Act Funding
PwC identified accounting for the U.S. CHIPS Act funding agreements as the sole critical audit matter: "The Company has entered into direct funding agreements with the U.S. Department of Commerce for up to $6.4 billion in direct funding pursuant to the U.S. CHIPS Act for the Company's U.S. manufacturing expansion and modernization projects in Idaho, New York, and Virginia."
PwC noted the complexity: "Funding will be based on the achievement of construction, tool installation, and wafer production milestones. The agreements contain representations, warranties, and covenants that relate to compliance with requirements for awards. The agreements include certain events of default and related rights and remedies, including clawbacks related to the failure to complete a project by an agreed upon completion date, violation of U.S. CHIPS Act restrictions on certain activities involving foreign countries and entities of concern."
The key accounting judgment is when to recognize government incentives — specifically whether milestones have been achieved and whether "there is reasonable assurance that the conditions of the government incentives are met." Given Micron recognized $2.01B in government incentive proceeds in FY2025, the timing and conditions of recognition are material.
Key Risks from Item 1A
1. Cyclicality. The 10-K warns of "volatility in average selling prices of our products" and "a range of factors that may adversely affect our gross margins." Memory prices can crash rapidly when supply exceeds demand.
2. Massive CapEx concentration risk. Micron has plans "to construct new fabrication facilities and/or ramp production at existing fabrication facilities. Increases in worldwide supply of semiconductor memory and storage, if not accompanied by commensurate increases in demand, could lead to declines in average selling prices."
3. Geopolitical risk. The filing lists "international operations, including geopolitical risks" as a key factor. Micron operates fabs in Taiwan, China, Japan, and Singapore — each carrying distinct geopolitical exposure.
4. Customer concentration. Per the risk factors: "dependency on certain customers, including international customers, and end markets." The AI boom has concentrated demand among a handful of hyperscale customers.
5. CHIPS Act clawback risk. If Micron fails to meet project milestones or violates restrictions on foreign activities, up to $6.4B in government funding could be subject to clawback.
Altman Z-Score and F-Score
| Model | Score | Interpretation |
|---|---|---|
| Altman Z-Score | **6.10** | Safe zone (>2.99). Strong |
| F-Score (Dechow) | **0.59** | Very low fraud probability (0.22%) |
The Z-Score of 6.10 confirms solid financial health. The F-Score of 0.59 produces an exceptionally low fraud probability of 0.22% — driven by the low soft asset ratio (0.31) reflecting Micron's tangible, fab-heavy balance sheet, and the strongly negative TATA.
Summary
| # | Check | Result |
|---|---|---|
| A1-A3 | Revenue Quality | Pass-Pass-Pass |
| B1-B4 | Expense Quality | Pass-Pass-Pass-Watch |
| C1-C4 | Cash Flow Quality | Pass-Fail-Pass-Watch |
| D1-D4 | Balance Sheet | Pass-Pass-Pass-Pass |
| E1-E2 | M&A Risk | Pass-Pass |
| F1 | Beneish M-Score | Pass |
Grade: C. The grade reflects capital intensity, not earnings manipulation.
Micron's C grade stems from one fail (FCF persistently below 50% of net income) and two watch items (gross margin swing, cash vs debt). All are explainable by the cyclical semiconductor memory business and the massive CapEx cycle:
The key question for investors is not "are the earnings real?" (they clearly are) but "will the $15.9B in annual CapEx generate returns, or will overcapacity crush pricing again?" That is a business risk, not an accounting risk.
**Disclaimer**: This report is based on Micron's FY2025 10-K (SEC EDGAR, fiscal year ended August 28, 2025) and public financial data. This is NOT investment advice.
Data: SEC EDGAR 10-K (Fiscal year ended August 28, 2025) + Yahoo Finance
Auditor: PricewaterhouseCoopers LLP (Unqualified opinion, 1 critical audit matter)
